203 related articles for article (PubMed ID: 26281354)
1. [GPER receptor - the new player in estrogen signaling].
Cygankiewicz AI; Jacenik D; Krajewska WM
Postepy Biochem; 2015; 61(1):52-60. PubMed ID: 26281354
[TBL] [Abstract][Full Text] [Related]
2. GPER Mediates Non-Genomic Effects of Estrogen.
Pupo M; Maggiolini M; Musti AM
Methods Mol Biol; 2016; 1366():471-488. PubMed ID: 26585158
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
Li Y; Birnbaumer L; Teng CT
Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
[TBL] [Abstract][Full Text] [Related]
4. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled estrogen receptor is required for the neuritogenic mechanism of 17β-estradiol in developing hippocampal neurons.
Ruiz-Palmero I; Hernando M; Garcia-Segura LM; Arevalo MA
Mol Cell Endocrinol; 2013 Jun; 372(1-2):105-15. PubMed ID: 23545157
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
7. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
[TBL] [Abstract][Full Text] [Related]
8. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
10. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
[TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells.
Teng Y; Radde BN; Litchfield LM; Ivanova MM; Prough RA; Clark BJ; Doll MA; Hein DW; Klinge CM
J Biol Chem; 2015 Jun; 290(25):15799-15811. PubMed ID: 25969534
[TBL] [Abstract][Full Text] [Related]
12. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled estrogen receptor 1 (GPER 1) mediates estrogen-induced, proliferation of leiomyoma cells.
Jiang X; Ye X; Ma J; Li W; Wu R; Jun L
Gynecol Endocrinol; 2015; 31(11):894-8. PubMed ID: 26416628
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen regulation of bone growth and endocrine function in the ovariectomized rat: discrimination of responses involving estrogen receptor α/estrogen receptor β, G protein-coupled estrogen receptor, or estrogen-related receptor γ using fulvestrant (ICI 182780).
Fitts JM; Klein RM; Powers CA
J Pharmacol Exp Ther; 2011 Jul; 338(1):246-54. PubMed ID: 21464335
[TBL] [Abstract][Full Text] [Related]
17. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
19. Not lost in translation: Emerging clinical importance of the G protein-coupled estrogen receptor GPER.
Barton M
Steroids; 2016 Jul; 111():37-45. PubMed ID: 26921679
[TBL] [Abstract][Full Text] [Related]
20. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]